Analogic Expects Solid Q2F11 Results on Medical Recovery, Says Benchmark

According to Benchmark, Analogic Corporation ALOG expects solid Q2F11 results on medical recovery. Benchmark reported that it expects a good quarter on continued medical recovery and steady security. “Analogic is scheduled to report its Q2FY11 results on Thursday, March 10th, after the close. The call is at 5 PM EST. We believe ALOG will likely report an in-line quarter from strength in medical. Q2FY11 consensus sales and EPS estimates are $111 million and $0.46 vs. our estimates of $107 million and $0.44. Our estimates assume a conservative 5% growth in medical imaging revenue, which includes digital mammography, double-digit growth in specialized ultrasound, and $10+ million in security revenue from the backlog.” Analogic closed yesterday at $52.90.